Equity Profile

CYRX

Cryoport, Inc.

Health CareLife Sciences Tools & Services$791.8M

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Cryoport, Inc. is a healthcare company that specializes in providing temperature-controlled logistics solutions for the life sciences industry....

Key Metrics to Watch

Revenue

As a key indicator of business performance, revenue will help assess the company's growth trajectory and market demand for its services.

N/A

Earnings Per Share (EPS)

EPS is crucial for understanding profitability and will indicate whether the company is moving towards financial stability.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CYRX Q2-2026 Earnings Preview

Context

Company Snapshot

Cryoport, Inc. is a healthcare company that specializes in providing temperature-controlled logistics solutions for the life sciences industry. Their services are critical for the safe transport of biological materials, which is increasingly important as the demand for advanced therapies and personalized medicine grows.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+98.90%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, Cryoport reported an EPS of -$0.25, missing estimates by 25%. The stock reacted negatively, declining by 1.35% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Cryoport's upcoming earnings are mixed, given the company's recent performance and lack of analyst estimates.

Bull Case

If Cryoport can demonstrate significant revenue growth and improve its EPS, it may regain investor confidence and see a positive stock reaction.

Bear Case

Conversely, if the company continues to miss earnings expectations and fails to provide clear guidance, it could face further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

The EPS figure will be critical in determining whether Cryoport is making progress towards profitability or continuing to struggle.

What revenue growth can Cryoport report this quarter?

Revenue growth is essential to assess the company's ability to capitalize on market opportunities and improve its financial health.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cryoport's potential for revenue growth as the demand for temperature-controlled logistics increases in the life sciences sector.

Supporting Evidence

The options market is pricing in a 25.97% move, suggesting that significant volatility is expected, which may not align with a cautious consensus.

Cryoport's recent history of surprising the market with earnings, despite recent misses, indicates potential for a turnaround.

Key Risk

If Cryoport reports an EPS better than -$0.20, it could challenge the current negative sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Cryoport's ability to improve its earnings and revenue amidst a challenging environment.

Bull Confirmed If

A positive EPS of -$0.20 or better would confirm the bull case and suggest a turnaround in financial performance.

Bear Confirmed If

An EPS worse than -$0.30 would confirm the bear case and indicate ongoing challenges for the company.

Pre-Earnings Positioning

Options Market

Implied Move

±25.97%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±26.0% while CYRX has averaged ±3.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

69.4%

Calls (307K)P/C Ratio: 0.00Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cryoport beats expectations, history suggests a potential stock increase of around 1.99%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 2.78%, reflecting ongoing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Details on operational improvements that may lead to cost reductions.
3Management's commentary on market trends in temperature-controlled logistics.
4Insights into customer demand for Cryoport's services in the life sciences sector.
5Any guidance on future earnings expectations or strategic initiatives.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Cryoport, Inc. is a healthcare company that specializes in providing temperature-controlled logistics solutions for the life sciences industry....

Key Metrics to Watch

Revenue

As a key indicator of business performance, revenue will help assess the company's growth trajectory and market demand for its services.

N/A

Earnings Per Share (EPS)

EPS is crucial for understanding profitability and will indicate whether the company is moving towards financial stability.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

CYRX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+98.90%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, Cryoport reported an EPS of -$0.25, missing estimates by 25%. The stock reacted negatively, declining by 1.35% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Cryoport's upcoming earnings are mixed, given the company's recent performance and lack of analyst estimates.

Bull Case

If Cryoport can demonstrate significant revenue growth and improve its EPS, it may regain investor confidence and see a positive stock reaction.

Bear Case

Conversely, if the company continues to miss earnings expectations and fails to provide clear guidance, it could face further stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

The EPS figure will be critical in determining whether Cryoport is making progress towards profitability or continuing to struggle.

What revenue growth can Cryoport report this quarter?

Revenue growth is essential to assess the company's ability to capitalize on market opportunities and improve its financial health.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Cryoport's potential for revenue growth as the demand for temperature-controlled logistics increases in the life sciences sector.

Supporting Evidence

The options market is pricing in a 25.97% move, suggesting that significant volatility is expected, which may not align with a cautious consensus.

Cryoport's recent history of surprising the market with earnings, despite recent misses, indicates potential for a turnaround.

Key Risk

If Cryoport reports an EPS better than -$0.20, it could challenge the current negative sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching Cryoport's ability to improve its earnings and revenue amidst a challenging environment.

Bull Confirmed If

A positive EPS of -$0.20 or better would confirm the bull case and suggest a turnaround in financial performance.

Bear Confirmed If

An EPS worse than -$0.30 would confirm the bear case and indicate ongoing challenges for the company.

Pre-Earnings Positioning

Options Market

Implied Move

±25.97%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±26.0% while CYRX has averaged ±3.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

69.4%

Calls (307K)P/C Ratio: 0.00Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cryoport beats expectations, history suggests a potential stock increase of around 1.99%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline of about 2.78%, reflecting ongoing concerns about the company's performance.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Details on operational improvements that may lead to cost reductions.
3Management's commentary on market trends in temperature-controlled logistics.
4Insights into customer demand for Cryoport's services in the life sciences sector.
5Any guidance on future earnings expectations or strategic initiatives.